Construction and verification of prognostic nomogram for early-onset esophageal cancer

被引:19
作者
Liu, Xiaoxiao [1 ]
Guo, Wei [1 ]
Shi, Xiaobo [1 ]
Ke, Yue [1 ]
Li, Yuxing [1 ]
Pan, Shupei [1 ]
Jin, Yingying [1 ]
Wang, Yuchen [1 ]
Ruan, Qinli [1 ]
Ma, Hongbing [1 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Radiat Oncol, 157 Xi Wu Rd, Xian, Shaanxi, Peoples R China
基金
中国国家自然科学基金;
关键词
Early-onset esophageal cancer (EOEC); nomogram; overall survival (OS); cancer-specific survival (CSS); surveillance; epidemiology; and end results (SEER); ADENOCARCINOMA; CARCINOMA; YOUNG;
D O I
10.17305/bjbms.2021.5533
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This study aimed to build up nomogram models to evaluate overall survival (OS) and cancer-specific survival (CSS) in early-onset esophageal cancer (EOEC). Patients diagnosed with esophageal cancer (EC) from 2004 to 2015 were extracted from the Surveillance Epidemiology and End Results (SEER) database. Clinicopathological characteristics of younger versus older patients were compared, and survival analysis was performed in both groups. Independent related factors influencing the prognosis of EOEC were identified by univariate and multivariate Cox analysis, which were incorporated to construct a nomogram. The predictive capability of the nomogram was estimated by the concordance index (C-index), calibration plot, receiver operating characteristic (ROC) curve, and decision curve analysis (DCA). A total of 534 younger and 17,243 older patients were available from the SEER database. Younger patients were randomly segmented into a training set (n = 266) and a validation set (n = 268). In terms of the training set, the C-index of the OS nomogram was 0.740 (95% CI: 0.707-0.773), and that of the CSS nomogram was 0.752 (95% CI: 0.719-0.785). In view of the validation set, the C-index of OS and CSS were 0.706 (95% CI: 0.671-0.741) and 0.723 (95% CI: 0.690-0.756), respectively. Calibration curves demonstrated the consistent degree of fit between actual and predicted values in nomogram models. From the perspective of DCA, the nomogram models were more beneficial than the tumor-node-metastasis (TNM) and the SEER stage for EOEC. In brief, the nomogram models can be considered as an individualized quantitative tool to predict the prognosis of EOEC patients to assist clinicians in making treatment decisions.
引用
收藏
页码:759 / 771
页数:13
相关论文
共 35 条
  • [1] Overview of esophageal cancer
    Abbas, Ghulam
    Krasna, Mark
    [J]. ANNALS OF CARDIOTHORACIC SURGERY, 2017, 6 (02) : 131 - 136
  • [2] Adam DJ, 1996, J ROY COLL SURG EDIN, V41, P371
  • [3] The effect of tumor locations of esophageal cancer on the metastasis to liver or lung
    Ai, Dashan
    Chen, Yun
    Liu, Qi
    Deng, Jiaying
    Zhao, Kuaile
    [J]. JOURNAL OF THORACIC DISEASE, 2019, 11 (10) : 4205 - 4210
  • [4] Global incidence of oesophageal cancer by histological subtype in 2012
    Arnold, Melina
    Soerjomataram, Isabelle
    Ferlay, Jacques
    Forman, David
    [J]. GUT, 2015, 64 (03) : 381 - 387
  • [5] Androgen receptors may act in a paracrine manner to regulate oesophageal adenocarcinoma growth
    Awan, A. K.
    Iftikhar, S. Y.
    Morris, T. M.
    Clarke, P. A.
    Grabowska, A. M.
    Waraich, N.
    Watson, S. A.
    [J]. EJSO, 2007, 33 (05): : 561 - 568
  • [6] Nomograms and medicine
    Bianco, Fernando J., Jr.
    [J]. EUROPEAN UROLOGY, 2006, 50 (05) : 884 - 886
  • [7] Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age
    Brown, Linda Morris
    Devesa, Susan S.
    Chow, Wong-Ho
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (16) : 1184 - 1187
  • [8] X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
    Camp, RL
    Dolled-Filhart, M
    Rimm, DL
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (21) : 7252 - 7259
  • [9] Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
    Feng, Rui-Mei
    Zong, Yi-Nan
    Cao, Su-Mei
    Xu, Rui-Hua
    [J]. CANCER COMMUNICATIONS, 2019, 39
  • [10] PD-1 Inhibitors in the Advanced Esophageal Cancer
    Hong, Ye
    Ding, Zhen-Yu
    [J]. FRONTIERS IN PHARMACOLOGY, 2019, 10